Legal Representation
Attorney
Andrew Baum
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 15, 2016 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 14, 2016 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 9, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 9, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 9, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 2, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2015 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 14, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 13, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Consulting and research services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to and use of computer software and algorithms for medical diagnostic and treatment purposes; providing access to f online software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols; mobile applications and services for mobile devices, namely, smart phones and tablets, and web applications accessible through the Internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording ENGINEUS with two circles extended out from the letter "g". Below is the stylized wording THE HEALTHCARE DECISION ENGINE.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ENGINE US THE HEALTH CARE DECISION ENGINE
Classification
International Classes
044